Astrotech Corporation (NASDAQ:ASTC – Get Free Report) was the recipient of a large growth in short interest during the month of February. As of February 27th, there was short interest totaling 29,521 shares, a growth of 30.4% from the February 12th total of 22,640 shares. Currently, 2.0% of the company’s stock are sold short. Based on an average trading volume of 7,455 shares, the days-to-cover ratio is presently 4.0 days. Based on an average trading volume of 7,455 shares, the days-to-cover ratio is presently 4.0 days. Currently, 2.0% of the company’s stock are sold short.
Wall Street Analysts Forecast Growth
Separately, Weiss Ratings reiterated a “sell (e+)” rating on shares of Astrotech in a report on Monday, December 29th. One research analyst has rated the stock with a Sell rating, Based on data from MarketBeat.com, the company currently has an average rating of “Sell”.
Check Out Our Latest Analysis on ASTC
Institutional Investors Weigh In On Astrotech
Astrotech Price Performance
Astrotech stock opened at $2.29 on Friday. Astrotech has a one year low of $2.25 and a one year high of $8.01. The business has a fifty day moving average price of $3.11 and a 200-day moving average price of $3.78. The firm has a market capitalization of $4.03 million, a P/E ratio of -0.27 and a beta of 0.38.
Astrotech (NASDAQ:ASTC – Get Free Report) last released its quarterly earnings data on Friday, February 13th. The aerospace company reported ($2.34) earnings per share (EPS) for the quarter. The company had revenue of $0.15 million for the quarter. Astrotech had a negative net margin of 1,163.89% and a negative return on equity of 68.53%.
About Astrotech
Astrotech Corp. (NASDAQ: ASTC) is a technology commercialization company headquartered near Austin, Texas. The firm sources early-stage innovations from government and university research programs—most notably from NASA—and advances them toward commercial readiness. Astrotech’s core mission is to bridge the gap between federally funded R&D and industrial applications across the life sciences and renewable energy sectors.
In its life sciences division, Astrotech has focused on mass spectrometry-based analytical instruments and diagnostic platforms.
Further Reading
- Five stocks we like better than Astrotech
- The gold chart Wall Street is terrified of…
- Elon Musk already made me a “wealthy man”
- Silver paying 20% dividend. Plus 68% share gains
- Unlocked: Elon Musk’s Next Big IPO
- A personal warning from Martin Weiss (Please read)
Receive News & Ratings for Astrotech Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Astrotech and related companies with MarketBeat.com's FREE daily email newsletter.
